147 related articles for article (PubMed ID: 12851535)
1. Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction.
Myers B; Westby J; Strong J
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):485-7. PubMed ID: 12851535
[TBL] [Abstract][Full Text] [Related]
2. Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy.
Gill J; Kovacs MJ
Obstet Gynecol; 1997 Oct; 90(4 Pt 2):648-50. PubMed ID: 11770579
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
Lindhoff-Last E; Bauersachs R
Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
[TBL] [Abstract][Full Text] [Related]
4. Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
Woo YL; Allard S; Cohen H; Letsky E; de Swiet M
BJOG; 2002 Apr; 109(4):466-8. PubMed ID: 12013171
[No Abstract] [Full Text] [Related]
5. On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.
Schenk JF; Pindur G; Stephan B; Mörsdorf S; Mertzlufft F; Kroll H; Wenzel E; Seyfert UT
Clin Appl Thromb Hemost; 2003 Jan; 9(1):25-32. PubMed ID: 12643320
[TBL] [Abstract][Full Text] [Related]
6. [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].
Schindewolf M; Magnani HN; Lindhoff-Last E
Hamostaseologie; 2007 May; 27(2):89-97. PubMed ID: 17479171
[TBL] [Abstract][Full Text] [Related]
7. Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.
Schindewolf M; Lindhoff-Last E
Thromb Haemost; 2008 Apr; 99(4):776-8. PubMed ID: 18392337
[No Abstract] [Full Text] [Related]
8. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
Tardy-Poncet B; Tardy B; Reynaud J; Mahul P; Mismetti P; Mazet E; Guyotat D
Chest; 1999 Jun; 115(6):1616-20. PubMed ID: 10378558
[TBL] [Abstract][Full Text] [Related]
10. Management of heparin allergy during pregnancy with danaparoid.
Harrison SJ; Rafferty I; McColl MD
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):157-9. PubMed ID: 11302479
[TBL] [Abstract][Full Text] [Related]
11. [[Treatment with danaparoid during pregnancy for a woman with a cutenous allergy to low-molecular-weight heparin] ].
de Saint-Blanquat L; Simon L; Toubas MF; Hamza J
Ann Fr Anesth Reanim; 2000 Dec; 19(10):751-4. PubMed ID: 11200764
[TBL] [Abstract][Full Text] [Related]
12. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
Ibbotson T; Perry CM
Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
[TBL] [Abstract][Full Text] [Related]
13. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
Ben Ami R; Rachmimov R; Berliner S
Harefuah; 1999 Mar; 136(5):361-4, 419. PubMed ID: 10914239
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P
Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327
[TBL] [Abstract][Full Text] [Related]
15. Safe anticoagulation with danaparoid in pregnancy and lactation.
Schindewolf M; Mosch G; Bauersachs RM; Lindhoff-Last E
Thromb Haemost; 2004 Jul; 92(1):211. PubMed ID: 15213864
[No Abstract] [Full Text] [Related]
16. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
Ranze O; Ranze P; Magnani HN; Greinacher A
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
[TBL] [Abstract][Full Text] [Related]
17. [Peri-operative anticoagulation with danaparoid for a patient with Budd-Chiari syndrome and heparin-induced thrombocytopenia].
Brémaud M; De Maistre E; Junke E; Guerci A; Lalot JM; Longrois D; Lecompte T; Meistelman C
Ann Fr Anesth Reanim; 2004 Feb; 23(1):50-5. PubMed ID: 14980323
[TBL] [Abstract][Full Text] [Related]
18. Treatment of 51 pregnancies with danaparoid because of heparin intolerance.
Lindhoff-Last E; Kreutzenbeck HJ; Magnani HN
Thromb Haemost; 2005 Jan; 93(1):63-9. PubMed ID: 15630492
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004.
Magnani HN; Gallus A
Thromb Haemost; 2006 Jun; 95(6):967-81. PubMed ID: 16732376
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
